Arrowhead Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

ARWR 7.22 -0.05 (-0.69%)
price chart
Option Market: Arrowhead Pharmaceuticals Inc Risk Hits A Notable High
This is a proprietary risk rating for the next 30-days built by Capital Market Laboratories (CMLviz) based on a large number of interactions of data points, many of which come directly from the option market for Arrowhead Pharmaceuticals Inc (NASDAQ ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) at $7.08: How much higher it can go
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) down -12.38% for the past 5 days, is under coverage of 6 analysts who collectively assign a hold rating on stock.
Monitor the Current Moves- Arrowhead Pharmaceuticals, Inc.'s (ARWR)  Hot Stocks Point
Cantor Sees 100% Upside for Arrowhead Pharmaceuticals Inc (ARWR) Shares
Cantor analyst Elemer Piros initiated coverage on shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), with a Buy rating and price target of $15, which represents a 100% increase from where the shares last closed.
Which way Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) insiders are heading  Review Fortune
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) Continues Upward Journey  Scibility Media
Chardan Weighs in on Arrowhead Pharmaceuticals Inc (ARWR) Following Phase II ...
This morning, Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced the initiation of its Phase II trial for its pipeline drug ARC-AAT, a RNAi based investigational medicine for alpha-1 antitrypsin (AAT) liver disease, set apart from current enzyme ...
Arrowhead Pharmaceuticals Doses First Patient with Hepatitis B in Multiple ...  Business Wire (press release)
Arrowhead Research Corp. (ARWR) Earns Buy Rating from Chardan Capital  Community Financial News
Cantor Reiterates Buy on Arrowhead Pharmaceuticals Inc Following Clinical ...
In a research report issued yesterday, Cantor analyst Elemer Piros reiterated a Buy rating on shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), with a price target of $15.00, after the biotech firm announced the initiation of the multiple ...
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Still Looks Cheap
Towards the end of August, we highlighted Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) as being a company down on its luck, but primed for recovery.
Arrowhead Pharmaceuticals Inc(NASDAQ:ARWR) target price increased to $15 as ...  Breaking Finance News
Brokers Update Target Prices On Arrowhead Research Corporation (NASDAQ:ARWR)  Fiscal Standard
analysts Estimates and Ratings: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) reported its last earnings on Aug 09 AMC (BMO = before market open, AMC= after market close).
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) at $7.75: How much higher it can go
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) up 26.63% for the past 5 days, is under coverage of 0 analysts who collectively assign a hold rating on stock.
Eye Catching Insider Trading and Recommendations: Arrowhead Pharmaceuticals ...  Post Registrar
Price Target Analysis: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) reported its last earnings on Aug 09 AMC (BMO = before market open, AMC= after market close).
Worth Watching Stocks: Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Novavax ...  Post Registrar
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Insiders Look Pessimistic About ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) up 11.32 per cent in the past week, is under coverage of 5 analysts who collectively recommend a hold rating on stock.
Company Update (NASDAQ:ARWR): Arrowhead Pharmaceuticals Inc Reports Fiscal ...  Smarter Analyst
Arrowhead Pharmaceuticals Inc. (ARWR) Jumps 8.31% on August 09  Equities.com